Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
2,717,290
-
Shares change
-
+327,046
-
Total reported value, excl. options
-
$47,597,000
-
Value change
-
+$6,006,830
-
Number of buys
-
13
-
Number of sells
-
-6
-
Price
-
$17.58
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q3 2018
24 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q3 2018.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,717,290 shares
of 29,067,614 outstanding shares and own 9.3% of the company stock.
Largest 10 shareholders include FMR LLC (935,400 shares), FRAZIER MANAGEMENT LLC (625,000 shares), Knoll Capital Management, LP (300,000 shares), Vanguard Group Inc (173,478 shares), Artal Group S.A. (150,000 shares), Tourbillon Capital Partners, L.P. (141,198 shares), BAKER BROS. ADVISORS LP (114,674 shares), S Squared Technology, LLC (53,900 shares), RENAISSANCE TECHNOLOGIES LLC (50,700 shares), and GEODE CAPITAL MANAGEMENT, LLC (36,466 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.